SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.884
AS - Asia 3.885
EU - Europa 2.561
SA - Sud America 625
AF - Africa 57
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.740
SG - Singapore 1.476
CN - Cina 1.333
UA - Ucraina 600
BR - Brasile 527
DE - Germania 412
GB - Regno Unito 400
HK - Hong Kong 364
TR - Turchia 327
IT - Italia 280
VN - Vietnam 181
PL - Polonia 179
SE - Svezia 159
FI - Finlandia 152
RU - Federazione Russa 119
FR - Francia 87
CA - Canada 68
MX - Messico 63
AR - Argentina 44
IN - India 44
BE - Belgio 39
NL - Olanda 38
ZA - Sudafrica 36
AT - Austria 35
JP - Giappone 29
BD - Bangladesh 24
ES - Italia 21
EC - Ecuador 20
ID - Indonesia 19
IQ - Iraq 18
IR - Iran 14
LT - Lituania 13
CO - Colombia 9
KR - Corea 9
PK - Pakistan 7
PY - Paraguay 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
EG - Egitto 6
UY - Uruguay 6
UZ - Uzbekistan 6
JM - Giamaica 5
MA - Marocco 5
NZ - Nuova Zelanda 5
IL - Israele 4
NP - Nepal 4
RO - Romania 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
DZ - Algeria 3
EU - Europa 3
MZ - Mozambico 3
OM - Oman 3
PH - Filippine 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CH - Svizzera 2
DK - Danimarca 2
JO - Giordania 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MD - Moldavia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.025
Salva come PNG Salva come JPEG
Città #
Singapore 905
Woodbridge 891
Fairfield 841
Ashburn 794
Jacksonville 619
Houston 603
Chandler 504
Ann Arbor 458
Beijing 427
Santa Clara 401
Hong Kong 363
Seattle 334
Wilmington 331
Cambridge 282
Nanjing 194
New York 194
Izmir 188
Warsaw 169
Los Angeles 136
Princeton 134
Dallas 120
San Diego 87
Munich 78
Buffalo 76
Boardman 60
Ho Chi Minh City 59
Shenyang 58
Milan 57
Shanghai 57
São Paulo 53
Tianjin 51
Mexico City 48
Hanoi 47
Nanchang 47
Brussels 39
Hefei 39
Hebei 38
Jiaxing 37
Chicago 34
San Mateo 34
Ferrara 32
Frankfurt am Main 29
Vienna 29
The Dalles 28
Changsha 26
Orem 26
Brooklyn 25
Tokyo 25
Helsinki 24
Jinan 24
Toronto 24
Ningbo 23
London 22
Norwalk 20
Falls Church 19
Guangzhou 19
Moscow 19
Philadelphia 19
San Francisco 19
Washington 19
Chennai 18
Denver 18
Johannesburg 18
Stockholm 18
Montreal 17
Mountain View 17
Turku 17
Augusta 15
Boston 15
Dearborn 15
Kunming 15
Leawood 15
Poplar 15
Rio de Janeiro 15
Auburn Hills 14
Ankara 13
Amsterdam 12
Falkenstein 12
Orange 12
Zhengzhou 12
Belo Horizonte 11
Council Bluffs 11
Redwood City 11
Taizhou 11
Verona 11
Ardabil 10
Atlanta 10
Bologna 10
Curitiba 10
Phoenix 10
Columbus 9
Hải Dương 9
Jakarta 9
Biên Hòa 8
Brasília 8
Monmouth Junction 8
Ottawa 8
Porto Alegre 8
Quito 8
Wroclaw 8
Totale 10.849
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 285
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 236
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 226
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 219
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 213
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 213
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 209
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 208
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 205
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 199
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 192
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 189
HSV as a vector in vaccine development and gene therapy 179
null 179
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 177
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 176
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 175
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 171
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 170
Replication-competent herpes simplex vectors: design and applications 167
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 166
Membrane protein pattern in hereditary spherocytosis in five subjects from north-east Italy obtained by SDS-PAGE using N,N'-diallyltartardiamide 163
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 163
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 162
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 161
Herpes Simplex Virus Growth, Preparation, and Assay 161
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 160
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 159
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 158
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 155
HSV as a vector in vaccine development and gene therapy 155
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 154
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 153
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 152
Capitolo 55 Retrovirus 150
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 150
Herpesvirus-based vaccines 150
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 148
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 145
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 145
Purinergic Signaling: A New Pharmacological Target Against Viruses? 143
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 141
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 140
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 139
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 139
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 139
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 138
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 137
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 137
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 137
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 136
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 136
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 136
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 135
Herpesvirus/retrovirus chimeric vectors 133
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 132
Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody. 131
State of viral DNA in BK virus-transformed rabbit cells 131
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 130
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 125
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 125
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 124
Comparative analysis of the virion polypeptides specified by Herpes simplex virus type 2 strains 124
Capitolo 44 Herpesviridae 122
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 119
HSV-1 virions engineered for specific binding to cell surface receptors 119
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 118
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 117
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 116
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 115
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 114
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 113
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 113
Molecular diagnosis of herpes simplex encephalitis 110
null 107
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 106
Transformation by defined regions of herpes simplex virus DNA. 105
Experimental keratitis in rabbits by human HSV-1 variants: prevention andtreatment 105
null 104
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 104
null 104
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 103
null 99
Gene therapy of the nervous system by herpes virus vectors 95
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 95
null 95
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 94
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 94
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 94
Ocular disease patterns caused by genetically related mutants of herpes simplex virus type I 94
Niosomes containing HSV immunogens as possible vaccine against genital herpes 91
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 90
Niosomes for vaginal administration of an antiherpetic peptide 89
null 89
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 88
null 88
null 88
Molecular approaches to inhibit HIV-1 tat expression and functions 88
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 87
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 87
Totale 13.945
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.865
Totale 77.593
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021914 0 0 0 0 0 173 65 175 24 175 227 75
2021/20221.407 58 137 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/20252.197 59 48 186 88 280 249 51 97 270 257 332 280
2025/20263.843 755 273 643 959 1.054 159 0 0 0 0 0 0
Totale 16.119